JPMorgan Chase & Co. Lowers Victrex (LON:VCT) Price Target to GBX 625

Victrex (LON:VCT) had its price target decreased by JPMorgan Chase & Co. from GBX 725 to GBX 625 in a report issued on Wednesday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 14.26% from the company’s current price.

Separately, Deutsche Bank Aktiengesellschaft cut their price target on shares of Victrex from GBX 850 to GBX 780 and set a “hold” rating for the company in a report on Tuesday, December 2nd. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of GBX 756.25.

Victrex Trading Down 2.3%

Shares of VCT stock opened at GBX 547 on Wednesday. The stock has a 50-day simple moving average of GBX 676.63 and a 200 day simple moving average of GBX 668.48. The stock has a market capitalization of £476.29 million, a P/E ratio of 17.20, a P/E/G ratio of 1.92 and a beta of 0.65. Victrex has a fifty-two week low of GBX 534.88 and a fifty-two week high of GBX 994. The company has a quick ratio of 1.99, a current ratio of 3.01 and a debt-to-equity ratio of 11.30.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.